Peregrine Capital Management LLC purchased a new position in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 882,983 shares of the biotechnology company’s stock, valued at approximately $3,991,000. Peregrine Capital Management LLC owned 0.39% of ADMA […]
ADMA Biologics (NASDAQ:ADMA) Sets New 12-Month High at $6 69 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
ADMA Biologics (NASDAQ:ADMA – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a note issued to investors on Tuesday, Benzinga reports. They currently have a $7.50 price objective on the biotechnology company’s stock, up from their prior price objective of $6.00. HC Wainwright’s price target would […]